Dacomitinib (PF-00299804)
Suppliers
Names
[ CAS No. ]:
1110813-31-4
[ Name ]:
Dacomitinib (PF-00299804)
[Synonym ]:
Dacomitinib [USAN]
Dacomitinib (USAN/INN)
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide
(2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide
(2E)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl}-4-(1-piperidinyl)-2-butenamide
Dacomitinib
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-, (2E)-
PF299804
PF-299804
Chemical & Physical Properties
[ Density]:
1.3±0.1 g/cm3
[ Boiling Point ]:
665.7±55.0 °C at 760 mmHg
[ Molecular Formula ]:
C24H25ClFN5O2
[ Molecular Weight ]:
469.939
[ Flash Point ]:
356.4±31.5 °C
[ Exact Mass ]:
469.168091
[ PSA ]:
82.87000
[ LogP ]:
5.12
[ Vapour Pressure ]:
0.0±2.0 mmHg at 25°C
[ Index of Refraction ]:
1.663
Safety Information
[ Hazard Codes ]:
Xi
[ HS Code ]:
29335990